Recently diagnosed with T1cN0M0 adenocarcinoma. Path indicates KRAS positive, with 40% solid component, 30%acinar, 30% micropapilllary. Had lobectomy of 2.8 x 1.6 cm mass on 1/31/18 with clear margins. 1 cm from nearest margin. Path also states PDL1 clone 22C5, tumor cells positive >95%. From what I've read the prognosis with KRAS and the solid/micropapillary findings are not as good. Based on the above info, would mop up chemo have any advantage at this time? Also, would immunetherapy be indicated by the PDL1 findings? Thanks for your input.
Thu, 03/08/2018 - 07:59#1
pursue mop up chemo? - 1294060